Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease

It is well accepted that the randomized controlled trial (RCT) is the best design for determining treatment effectiveness. Despite this, the surgical literature, particularly in the area of inflammatory bowel disease, is replete with case series while there is a paucity of RCTs assessing surgical in...

Full description

Saved in:
Bibliographic Details
Main Author: Robin S McLeod
Format: Article
Language:English
Published: Wiley 1995-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1995/653142
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547419890384896
author Robin S McLeod
author_facet Robin S McLeod
author_sort Robin S McLeod
collection DOAJ
description It is well accepted that the randomized controlled trial (RCT) is the best design for determining treatment effectiveness. Despite this, the surgical literature, particularly in the area of inflammatory bowel disease, is replete with case series while there is a paucity of RCTs assessing surgical interventions. There certainly is no lack of questions to be answered and there is a lack of consensus on many issues. Why then are there so few RCTs? Unfortunately, it appears that surgeons in general are more accepting of evidence from case series. However, it also appears that there are certain issues that are unique to, or at least occur more frequently in, clinical trials assessing surgical interventions. The issues of special concern in surgical trials can broadly be categorized as methodological and feasibility issues. Methodological issues include difficulties in standardization of the procedure, deciding on the timing of the trial and prevention of bias when blinding may be difficult or impossible. All these are challenges, but do not preclude the performance of RCTs. On the other hand, feasibility issues may pose more of a challenge. Patients may refuse entry, particularly if they view the two treatments as ‘unequal’ (eg, medical versus surgical therapy) and irreversible (as they usually are in surgery). Patient accrual may be difficult given the variable patterns of disease and indications for surgery. Finally, unlike medical therapies which are controlled by regulating agencies, surgical procedures can simply be performed and there may be little incentive, and even some disincentives, for the surgeon to participate in a trial. Despite these difficulties, better evaluation of surgical therapies is required. Where possible, RCTs should be performed, but in situations where this is not possible other trial designs must be employed that may lack some of the rigour of an RCT but that are more rigorous than the uncontrolled case series.
format Article
id doaj-art-305737dd741d493c8581115c8e960df8
institution Kabale University
issn 0835-7900
language English
publishDate 1995-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-305737dd741d493c8581115c8e960df82025-02-03T06:44:43ZengWileyCanadian Journal of Gastroenterology0835-79001995-01-019739339610.1155/1995/653142Special Problems Associated with Surgical Trials in Inflammatory Bowel DiseaseRobin S McLeod0Departments of Surgery and Preventive Medicine and Biostatistics, University of Toronto, Toronto, Ontario, CanadaIt is well accepted that the randomized controlled trial (RCT) is the best design for determining treatment effectiveness. Despite this, the surgical literature, particularly in the area of inflammatory bowel disease, is replete with case series while there is a paucity of RCTs assessing surgical interventions. There certainly is no lack of questions to be answered and there is a lack of consensus on many issues. Why then are there so few RCTs? Unfortunately, it appears that surgeons in general are more accepting of evidence from case series. However, it also appears that there are certain issues that are unique to, or at least occur more frequently in, clinical trials assessing surgical interventions. The issues of special concern in surgical trials can broadly be categorized as methodological and feasibility issues. Methodological issues include difficulties in standardization of the procedure, deciding on the timing of the trial and prevention of bias when blinding may be difficult or impossible. All these are challenges, but do not preclude the performance of RCTs. On the other hand, feasibility issues may pose more of a challenge. Patients may refuse entry, particularly if they view the two treatments as ‘unequal’ (eg, medical versus surgical therapy) and irreversible (as they usually are in surgery). Patient accrual may be difficult given the variable patterns of disease and indications for surgery. Finally, unlike medical therapies which are controlled by regulating agencies, surgical procedures can simply be performed and there may be little incentive, and even some disincentives, for the surgeon to participate in a trial. Despite these difficulties, better evaluation of surgical therapies is required. Where possible, RCTs should be performed, but in situations where this is not possible other trial designs must be employed that may lack some of the rigour of an RCT but that are more rigorous than the uncontrolled case series.http://dx.doi.org/10.1155/1995/653142
spellingShingle Robin S McLeod
Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
Canadian Journal of Gastroenterology
title Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
title_full Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
title_fullStr Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
title_full_unstemmed Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
title_short Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
title_sort special problems associated with surgical trials in inflammatory bowel disease
url http://dx.doi.org/10.1155/1995/653142
work_keys_str_mv AT robinsmcleod specialproblemsassociatedwithsurgicaltrialsininflammatoryboweldisease